Pages that link to "Q43612964"
Jump to navigation
Jump to search
The following pages link to Pharmacokinetic drug interaction potential of risperidone with cytochrome p450 isozymes as assessed by the dextromethorphan, the caffeine, and the mephenytoin test. (Q43612964):
Displaying 7 items.
- Cytochrome P450 2D6 dependent metabolization of risperidone is inhibited by melperone (Q28301803) (← links)
- Risperidone-associated diabetes mellitus: a pharmacovigilance study (Q35160244) (← links)
- Comparative cytochrome p450 in vitro inhibition by atypical antipsychotic drugs (Q36651297) (← links)
- Discovery of the nonfunctional CYP2D6 31 allele in Spanish, Puerto Rican, and US Hispanic populations. (Q43062018) (← links)
- Population pharmacokinetic analysis of drug-drug interactions among risperidone, bupropion, and sertraline in CF1 mice (Q46800432) (← links)
- A rapid and simple LC–MS/MS method for the simultaneous evaluation of CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 hydroxylation capacity (Q57585643) (← links)
- Study Protocol for a Pilot, Open-Label, Prospective, and Observational Study to Evaluate the Pharmacokinetics of Drugs Administered to Patients during Extracorporeal Circulation; Potential of In Vivo Cytochrome P450 Phenotyping to Optimise Pharmacot (Q92525221) (← links)